Prime Medicine PRME Cash Flow Statement (2021-2026)

NASDAQ PRME
$3.70 -0.01 (-0.27%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Prime Medicine Quarterly Cash Flow Statement

Periods 20 quarters
Latest Jun 2026

Prime Medicine reported cash from operations of -$41.05M and free cash flow of -$41.09M for the quarter ended Jun 2026, up 0.9% year over year. This cash flow statement covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -16.41M-62.90M-23.84M-29.35M-29.35M-39.28M-39.40M-42.38M-50.71M-65.64M-45.76M-55.33M-52.52M-42.28M-51.89M-52.59M-52.83M-47.52M-49.63M-42.50M
Share-based Compensation 2.16M1.12M27.45M0.02M1.68M3.58M4.22M4.43M44.94M83.76M4.64M4.87M
Deferred Taxes 1.24M-0.53M-0.44M0.21M-0.20M-0.20M0.03M-0.11M0.13M-0.13M
Cash from Operations -13.19M-50.79M-20.22M-30.10M-30.71M-41.56M-40.82M-39.17M-43.86M-67.71M-45.49M-25.91M16.25M-48.86M-41.41M-35.04M-37.26M-42.71M-41.05M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.38M1.77M2.45M2.77M2.80M2.83M3.47M3.14M3.35M3.35M4.57M2.23M2.21M2.41M2.35M2.33M2.60M2.84M2.87M
Depreciation & Amortization (CF)Depreciation & Amortization 0.20M0.26M0.29M0.43M0.63M0.87M1.05M1.12M1.24M1.25M1.31M1.54M1.56M1.72M1.70M1.86M1.88M1.88M1.86M1.78M
Change in Working Capital
Change in Receivables 55.00M0.02M0.10M-0.12M
Change in Account Payables 0.08M1.05M1.38M-0.40M0.43M-0.50M1.61M5.76M2.28M-5.88M-3.35M1.51M2.46M1.88M-3.35M3.04M-0.58M3.55M-6.52M
Change in Accured Expenses 33.31M-33.32M2.47M0.89M4.09M-4.05M0.61M2.68M2.51M-4.47M0.54M5.93M-0.14M-6.66M4.96M-1.07M1.60M-4.50M0.88M
Other Working Capital Changes -1.59M-2.31M-1.95M-3.30M-2.69M-2.78M-3.79M15.61M-21.34M-3.46M-2.21M15.14M6.39M-3.10M-2.84M-1.60M-1.71M-1.92M-2.03M
Investing Activities
Capital Expenditures 0.38M1.69M4.80M4.79M4.81M2.60M1.37M2.91M1.84M2.32M1.90M1.28M1.79M2.42M1.57M0.25M0.29M0.21M0.05M
Change in Acquisitions & Divestments 13.00M32.50M29.50M6.00M25.00M35.00M30.00M20.02M47.53M72.50M37.50M61.30M32.90M3.00M11.25M42.43M39.10M50.89M43.06M
Cash from Investing Activities 12.15M30.89M-50.79M-13.51M-13.69M-12.66M27.86M-37.77M41.28M-37.03M6.89M50.34M48.25M-47.74M2.77M-92.12M28.33M43.39M24.03M
Financing Activities
Other financing activities 0.06M185.25M0.07M0.07M0.32M0.19M18.80M0.37M0.41M0.39M0.02M
Misc.
Cash from Financing Activities -1.09M-1.27M-0.62M-0.68M184.07M0.07M0.07M0.32M0.19M157.33M0.04M38.51M0.00M6.00M0.20M144.75M0.56M0.39M0.36M
Change in Cash -2.12M-21.17M-71.64M-44.29M139.67M-54.16M-12.88M-76.62M-2.38M52.59M-38.56M62.94M64.50M-90.60M-38.44M17.59M-8.36M1.07M-16.66M
Free Cash Flow -13.57M-52.48M-25.02M-34.89M-35.53M-44.16M-42.19M-42.08M-45.70M-70.03M-47.39M-27.19M14.45M-51.28M-42.98M-35.29M-37.55M-42.92M-41.09M
Net Cash Flow -2.12M-21.17M-71.64M-44.29M139.67M-54.16M-12.88M-76.62M-2.38M52.59M-38.56M62.94M64.50M-90.60M-38.44M17.59M-8.36M1.07M-16.66M